Anebulo Pharmaceuticals (ANEB) Cash & Equivalents (2020 - 2025)
Anebulo Pharmaceuticals (ANEB) recorded Cash & Equivalents of $9.04 million in fiscal Q2 2026 (quarter ended Dec 31, 2025), down 39.7% from $15 million a year earlier and down 12.7% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Cash & Equivalents (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals reported Cash & Equivalents of $11.63 million, up 275.8% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of 30.9% (FY2020 to FY2025).
- Across earlier fiscal years, Cash & Equivalents came in at $3.09 million in FY2024 (-72.5%), $11.25 million in FY2023 (-22.7%), $14.55 million in FY2022 (-27.2%) and $19.99 million in FY2021 (+560.7%).
- The fiscal Q2 2026 figure is the lowest quarterly Cash & Equivalents since fiscal Q1 2025.
- On a year-over-year basis, Cash & Equivalents rose in four of the last eight quarters, with growth averaging 117.2%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 637.4% in fiscal Q1 2026, against a decline of 83.5% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $10.35 million (Q1 2026), $11.63 million (Q4 2025) and $13.28 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Anebulo Pharmaceuticals | 13.15 Mn | 13.15 Mn | - | 9.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.04 Mn |
| Sep 30, 2025 | 10.35 Mn |
| Jun 30, 2025 | 11.63 Mn |
| Mar 31, 2025 | 13.28 Mn |
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 3.09 Mn |
| Mar 31, 2024 | 5.15 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 8.52 Mn |
| Jun 30, 2023 | 11.25 Mn |
| Mar 31, 2023 | 14.16 Mn |
| Dec 31, 2022 | 16.36 Mn |
| Sep 30, 2022 | 19.21 Mn |
| Jun 30, 2022 | 14.55 Mn |
| Mar 31, 2022 | 16.55 Mn |
| Dec 31, 2021 | 18.01 Mn |
| Sep 30, 2021 | 19.21 Mn |
| Jun 30, 2021 | 19.99 Mn |
| Mar 31, 2021 | 3.31 Mn |
API Access
Anebulo Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();